Cite
HARVARD Citation
Jilek, S. et al. (2014). Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients. Multiple sclerosis. pp. 837-842. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jilek, S. et al. (2014). Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients. Multiple sclerosis. pp. 837-842. [Online].